Results 171 to 180 of about 18,629 (186)

IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF

2018
BURAK ERIC STEVEN, FORBES JOHN RICHARD, MORAN MATTHEW DAVID BURR, SIMMS RYAN WAYNE, VALLIANT JOHN FITZMAURICE   +4 more
openaire   +3 more sources

An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis

Biochemical Pharmacology, 2004
exaly  

Cell death: The dark side of IGF-1R

Nature China, 2007
openaire   +1 more source

ANTI-IGF-1R ANTIBODY AND APPLICATIONS THEREOF

2021
GUO SHUHUA, MA LIN, ZHANG PENG
openaire   +2 more sources

MODIFIED HUMAN IGF-1R ANTIBODIES

2005
COHEN BRUCE DAVID, BEDIAN VAHE
openaire   +1 more source

Blockade of IGF-1R—not effective in neuroendocrine tumours

Nature Reviews Endocrinology, 2013
openaire   +1 more source

PODOPHYLLOTOXIN DERIVATIVES AS IGF-1R INHIBITORS

2005
AXELSON MAGNUS, LARSSON OLLE
openaire   +1 more source

The IGF-1R pathway as a therapeutic target.

Oncology (Williston Park, N.Y.), 2011
openaire   +1 more source

Composition for the treatment of IGF-1R expressing cancer

2020
JOUHANNEAUD ALEXANDRA, GOETSCH LILIANE, BROUSSAS MATTHIEU, BEAU-LARVOR CHARLOTTE, CHAMPION THIERRY, ROBERT ALAIN, HAEUW JEAN-FRANÇOIS, RILATT IAN, PEREZ MICHEL, LAMOTHE MARIE   +9 more
openaire   +1 more source

Markers for Assessing the Susceptibility of Cancer to IGF-1R Treatment

2011
WITTA SAMIR, YOSHIDA KOICHI, DZIADZIUSZKO RAFAL, HIRSCH FRED   +3 more
openaire   +2 more sources